Technical Analysis for PRGO - Perrigo Company

Grade Last Price % Change Price Change
grade F 52.63 -1.11% -0.59
PRGO closed down 1.11 percent on Thursday, August 13, 2020, on 76 percent of normal volume. The stock fell below its 200 day moving average, damaging its long-term outlook by crossing under that critical trendline.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Flat
Historical PRGO trend table...

Date Alert Name Type % Chg
Fell Below 200 DMA Bearish 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Calm After Storm Range Contraction 0.00%
Outside Day Range Expansion 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -1.11%
Crossed Above 200 DMA Bullish -1.11%
Calm After Storm Range Contraction -1.11%
Narrow Range Bar Range Contraction -1.11%
NR7 Range Contraction -1.11%
Inside Day Range Contraction -1.11%

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Perrigo Company, through its subsidiaries, develops, manufactures, and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, nutritional products, and active pharmaceutical ingredients (API) primarily in the United States, Israel, the United Kingdom, Mexico, and Australia. The company operates in four segments: Consumer Healthcare, Nutritionals, Rx Pharmaceuticals, and API. The Consumer Healthcare segment offers OTC pharmaceutical products in the areas of analgesics, cough/cold/allergy/sinus, gastrointestinal, smoking cessation, feminine hygiene, diabetes care, and dermatological care, as well as in the areas of animal health category. The Nutritionals segment develops, manufactures, markets, and distributes store brand infant and toddler formula products, infant and toddler foods, vitamins, mineral and dietary supplement products, and oral electrolyte solution products. The Rx Pharmaceuticals segment develops, manufactures, and markets a portfolio of generic prescription drugs in topical dosage forms, such as creams, ointments, lotions, gels, shampoos, foams, suppositories, sprays, liquids, suspensions, solutions, and powders, as well as controlled substances, injectables, hormones, and oral liquids and oral solid dosage forms. The API segment develops, manufactures, and markets API used by the generic drug industry and branded pharmaceutical companies. The company sells its products to drug stores, wholesalers, distributors, hospital systems, and group purchasing organizations. Perrigo Company was founded in 1887 and is headquartered in Allegan, Michigan.
Health Pharmaceutical Pharmaceutical Industry Pharmaceuticals Diabetes Pharmaceutical Products Active Pharmaceutical Ingredients Dietary Supplement Nutritional Products Diabetes Care Hospital Systems Perrigo

Is PRGO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 63.86
52 Week Low 40.01
Average Volume 888,106
200-Day Moving Average 53.12
50-Day Moving Average 54.76
20-Day Moving Average 54.63
10-Day Moving Average 52.64
Average True Range 1.73
ADX 19.74
+DI 20.45
-DI 25.04
Chandelier Exit (Long, 3 ATRs ) 53.63
Chandelier Exit (Short, 3 ATRs ) 54.76
Upper Bollinger Band 59.34
Lower Bollinger Band 49.92
Percent B (%b) 0.29
BandWidth 17.26
MACD Line -0.89
MACD Signal Line -0.63
MACD Histogram -0.2624
Fundamentals Value
Market Cap 7.51 Billion
Num Shares 143 Million
EPS -20.57
Price-to-Earnings (P/E) Ratio -2.56
Price-to-Sales 2.37
Price-to-Book 1.96
PEG Ratio 2.33
Dividend 0.64
Dividend Yield 1.22%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 54.20
Resistance 3 (R3) 54.34 53.97 53.94
Resistance 2 (R2) 53.97 53.57 53.89 53.85
Resistance 1 (R1) 53.30 53.32 53.11 53.15 53.76
Pivot Point 52.92 52.92 52.83 52.85 52.92
Support 1 (S1) 52.25 52.52 52.07 52.11 51.50
Support 2 (S2) 51.88 52.28 51.80 51.41
Support 3 (S3) 51.21 51.88 51.32
Support 4 (S4) 51.06